Selecting appropriate sites is one of the most crucial determinants of study success, yet efficient clinical trial site selection continues to be a prominent industry-wide challenge. Inability to meet planned recruitment timelines and failure to enroll participants impose an economic burden on sponsors, with downstream impacts on patients in the form of higher costs or even failed investigative drugs.
In a competitive environment where clinical trial designs are increasing in complexity and sites are becoming more selective about the studies they take on, sponsors are under pressure to take a nuanced approach to clinical trial site selection, one that leverages both traditional methods and innovative technologies.
This webinar will delve into the multifaceted process of clinical trial site selection, highlighting the importance of a methodology that incorporates stakeholder engagement, data-driven decision-making and the integration of technological solutions.
Register for this webinar today to gain insights into the multifaceted process of clinical trial site selection to increase the efficiency and quality of clinical trials.
Speaker
Nicole Stansbury, SVP, Global Clinical Operations, Premier Research
Nicole Stansbury, Senior Vice President, Global Clinical Operations, is responsible for the oversight of clinical operations, which includes clinical strategy and delivery, study start up, central monitoring and site management and risk-based monitoring at Premier Research. She leverages an innovative, data-driven approach and more than 25 years of industry experience to help sponsors address the rapidly evolving demands of the clinical development industry. In her role, Stansbury is focused on finding ways to simplify processes and improve technology adoption to decrease the time, cost, complexity and risk of delivering clinical research.
Prior to joining Premier Research, Stansbury held various CRO leadership positions where she was instrumental in the strategic implementation of risk-based monitoring, central monitoring and continuous improvement of clinical operations processes. Stansbury has been the Co-Lead for the Association of Clinical Research Organizations Risk-Based Monitoring (ACRO RBM) Working Group working with TransCelerate and the FDA since 2014.
She holds a Bachelor of Science from Texas A&M and a Lean Six Sigma – Yellow Belt certification.
Message PresenterWho Should Attend?
This webinar will benefit Managers and above at biotech and specialty pharma companies with job functions including, but not limited, to:
- Clinical Operations
- Medical Affairs
- Project Management
- Regulatory Affairs
What You Will Learn
Attendees will learn about:
- Challenges to efficient clinical trial site selection
- Tips for optimizing site feasibility assessments
- Strategies for decreasing cycle times
- Imagining a future of optimized clinical trial site selection
Xtalks Partner
Premier Research
Premier Research, a clinical research company, is dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments. As a global company, Premier specializes in the use of innovative technologies for smart study design and trial management to deliver clean, conclusive data to sponsors. Whether it’s developing product lifecycle strategies, reducing clinical development cycle times, securing access to patients, navigating global regulations, maximizing the impact of limited rare disease data, or providing expertise in specific therapeutic areas, Premier is committed to helping its customers answer the unmet needs of patients across a broad range of medical conditions. Visit premier-research.com.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account